Triazolam and Amitiza drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Triazolam (triazolam) and Amitiza (lubiprostone). Common drug interactions include cardiac failure acute among females and back disorder among males.

The phase IV clinical study analyzes what interactions people have when they take Triazolam and Amitiza. It is created by eHealthMe based on reports of 40 people who take the same drugs from the FDA, and is updated regularly.

What is Triazolam?

Triazolam has active ingredients of triazolam. It is often used in insomnia. eHealthMe is studying from 5,838 Triazolam users. Check the latest studies of Triazolam.

What is Amitiza?

Amitiza has active ingredients of lubiprostone. It is often used in constipation. eHealthMe is studying from 10,567 Amitiza users. Check the latest studies of Amitiza.



On Aug, 12, 2026

40 people who take Triazolam and Amitiza together, and have interactions are studied.

Triazolam and Amitiza drug interactions.

What are the common drug interactions of Triazolam and Amitiza, by gender? *:

female:

  1. Cardiac failure acute
  2. Chronic kidney disease
  3. Decreased appetite
  4. Ileus (a painful obstruction of the ileum or other part of the intestine)
  5. Inappropriate antidiuretic hormone secretion
  6. Malaise (a feeling of general discomfort or uneasiness)
  7. Osteomyelitis (infection of bone)
  8. Deafness
  9. Depressed level of consciousness
  10. Bipolar disorder (mood disorder)

male:

  1. Back disorder
  2. Drug withdrawal syndrome (interfere with normal social, occupational, or other functioning. are not due to another medical condition, drug use, or discontinuation)
  3. Liver abscess (pus in liver)
  4. Neutrophil count decreased (less than normal number of neutrophil a type of blood cell)
  5. Onychomycosis (fungal infection of the nail)
  6. Osteomyelitis (infection of bone)
  7. Renal disorder (kidney disease)
  8. Spider vein (small dilated blood vessels near the surface of the skin)
  9. Surgery
  10. Vasculitis (inflammation of a blood vessel or blood vessels)

What are the common drug interactions of Triazolam and Amitiza, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

  1. Chronic kidney disease

50-59:

  1. Osteomyelitis (infection of bone)
  2. Back disorder
  3. Drug withdrawal syndrome (interfere with normal social, occupational, or other functioning. are not due to another medical condition, drug use, or discontinuation)
  4. Neck deformity (neck malformation)
  5. Polyp
  6. Tendonitis (a condition that causes pain and swelling of tendons)
  7. Deafness
  8. Hypophysitis (inflammation of the pituitary gland)
  9. Intervertebral disc degeneration (spinal disc degeneration)
  10. Neutrophil count decreased (less than normal number of neutrophil a type of blood cell)

60+:

  1. Cardiac failure acute
  2. Decreased appetite
  3. Blood creatine phosphokinase increased
  4. Chest pain
  5. Dry skin
  6. Hyperchlorhydria (gastric acid levels are higher in stomach)
  7. Hypertension (high blood pressure)
  8. Hypotension (abnormally low blood pressure)
  9. Influenza like illness
  10. Lung neoplasm malignant (cancer tumour of lung)

What are the existing conditions these people have? *

  1. High Blood Pressure: 11 people, 27.50%
  2. Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 8 people, 20.00%
  3. Chronic Obstructive Pulmonary Disease (a progressive disease that makes it hard to breathe): 7 people, 17.50%
  4. Depression: 7 people, 17.50%
  5. Rheumatoid Arthritis (a chronic progressive disease causing inflammation in the joints): 6 people, 15.00%
  6. High Blood Cholesterol: 6 people, 15.00%
  7. Osteoporosis (bones weak and more likely to break): 6 people, 15.00%
  8. Stress And Anxiety: 4 people, 10.00%
  9. Pain: 4 people, 10.00%
  10. Infection: 4 people, 10.00%

* Approximation only. Some reports may have incomplete information.

Do you take Triazolam and Amitiza?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Triazolam and Amitiza:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Triazolam:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Amitiza:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Triazolam and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Amitiza and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on triazolam and lubiprostone (the active ingredients of Triazolam and Amitiza, respectively), and Triazolam and Amitiza (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: